Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Autoimmune Disorders

Free Subscription Articles published in J Neuroimmunol Retrieve available abstracts of 213 articles: HTML format

Single Articles

April 2008
1. MANGANO K , Dati G, Quattrocchi C, Proietti L, et al
   Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barre syndrome.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. RAMAGOPALAN SV , Dyment DA, Herrera BM, Deluca GC, et al
   Parental non-inherited HLA resistance alleles do not confer protection against multiple sclerosis.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. GRABER JJ , Allie SR, Mullen KM, Jones MV, et al
   Interleukin-17 in transverse myelitis and multiple sclerosis.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. GINI B , Laura L, Riccardo C, Laura C, et al
   Novel autoantigens recognized by CSF IgG from Hashimoto's encephalitis revealed by a proteomic approach.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. VAKNIN-DEMBINSKY A , Murugaiyan G, Hafler DA, Astier AL, et al
   Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. MALMESTROM C , Lycke J, Haghighi S, Andersen O, et al
   Relapses in multiple sclerosis are associated with increased CD8(+) T-cell mediated cytotoxicity in CSF.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   March 2008
7. NIKS EH , van Leeuwen Y, Leite MI, Dekker FW, et al
   Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. PAMPLIEGA O , Domercq M, Villoslada P, Sepulcre J, et al
   Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. WRAY BN , Stankovich J, Whittock L, Dwyer T, et al
   CTLA-4 and multiple sclerosis: The A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. UEMURA Y , Ohno H, Ohzeki Y, Takanashi H, et al
    The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. COUTURIER N , Zappulla JP, Lauwers-Cances V, Uro-Coste E, et al
    Mast cell transcripts are increased within and outside multiple sclerosis lesions.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. BRIANI C , Zara G, Alaedini A, Grassivaro F, et al
    Neurological complications of celiac disease and autoimmune mechanisms: A prospective study.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. AZOULAY D , Urshansky N, Karni A
    Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
14. MATESANZ F , Fernandez O, Milne RL, Fedetz M, et al
    The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. FURUKAWA Y , Yoshikawa H, Iwasa K, Yamada M, et al
    Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. ROMI FR , Gilhus NE, Luckman SP
    Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
17. CORREALE J , Villa A
    Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. CAPORALE CM , Uncini A, Giovannini A
    "Susceptibility to Guillain-Barre syndrome is associated to polymorphisms of CD1 genes" by Bang et al. in the J of Neuroimmunology (2007) 186, 201-202.
    J Neuroimmunol. 2008;.
    PubMed     Related articles   
    
    
    
19. KREMLEV SG , Gaurnier-Hausser AL, Del Valle L, Perez-Liz G, et al
    Angiocidin promotes pro-inflammatory cytokine production and antigen presentation in multiple sclerosis.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. ZHENG X , Hu X, Zhou G, Lu Z, et al
    Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. LI J , Tuzun E, Wu XR, Qi HB, et al
    Inhibitory IgG receptor FcgammaRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. LINDBERG RL , Achtnichts L, Hoffmann F, Kuhle J, et al
    Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. FUCHS S , Feferman T, Meidler R, Margalit R, et al
    A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. JACOBS BC , Koga M, van Rijs W, Geleijns K, et al
    Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barre syndrome.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. BAETEN K , Hendriks JJ, Hellings N, Theunissen E, et al
    Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. SMOLDERS J , Damoiseaux J, Menheere P, Hupperts R, et al
    Vitamin D as an immune modulator in multiple sclerosis, a review.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
27. MATYSIAK M , Stasiolek M, Orlowski W, Jurewicz A, et al
    Stem cells ameliorate EAE via an indoleamine 2,3-dioxygenase (IDO) mechanism.
    J Neuroimmunol. 2008;193.
    PubMed     Related articles    Abstract available
    
    
    
28. SONG L , Le J, Ye F, Shao H, et al
    Sequence 168 to 177 of interphotoreceptor retinoid-binding protein (IRBP) is an antigenic epitope for autoreactive CD8 T cells in the B10RIII mouse.
    J Neuroimmunol. 2008;193.
    PubMed     Related articles    Abstract available
    
    
    
29. MILWARD E , Kim KJ, Szklarczyk A, Nguyen T, et al
    Cleavage of myelin associated glycoprotein by matrix metalloproteinases.
    J Neuroimmunol. 2008;193.
    PubMed     Related articles    Abstract available
    
    
    
30. BROD SA , Hood ZM
    Ingested (oral) alpha-MSH inhibits acute EAE.
    J Neuroimmunol. 2008;193.
    PubMed     Related articles    Abstract available
    
    
    
31. ILYAS AA , Gu Y, Dalakas MC, Quarles RH, et al
    Induction of experimental ataxic sensory neuronopathy in cats by immunization with purified SGPG.
    J Neuroimmunol. 2008;193.
    PubMed     Related articles    Abstract available
    
    
    December 2007
32. ROOS IM , Kockum I, Hillert J
    The interleukin 23 receptor gene in multiple sclerosis: A case-control study.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. CHEN Z , Freedman MS
    Correlation of specialized CD16(+) gammadelta T cells with disease course and severity in multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. PARK IK , Hiraki K, Kohyama K, Matsumoto Y, et al
    Differential effects of decoy chemokine (7ND) gene therapy on acute, biphasic and chronic autoimmune encephalomyelitis: Implication for pathomechanisms of lesion formation.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. O'CONNOR RA , Anderton SM
    Foxp3(+) regulatory T cells in the control of experimental CNS autoimmune disease.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. PUISSANT-LUBRANO B , Viala F, Winterton P, Abbal M, et al
    Thymic output and peripheral T lymphocyte subsets in relapsing-remitting multiple sclerosis patients treated or not by IFN-beta.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
37. MOORE CS , Hebb AL, Robertson GS
    Inhibitor of apoptosis protein (IAP) profiling in experimental autoimmune encephalomyelitis (EAE) implicates increased XIAP in T lymphocytes.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. ABROMSON-LEEMAN S , Ladell DS, Bronson RT, Dorf ME, et al
    Heterogeneity of EAE mediated by multiple distinct T-effector subsets.
    J Neuroimmunol. 2007;192.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
39. FRAUSTO RF , Crocker SJ, Eam B, Whitmire JK, et al
    Myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiency.
    J Neuroimmunol. 2007;192.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
40. GILLI F , Marnetto F, Caldano M, Valentino P, et al
    Anti-interferon-beta neutralising activity is not entirely mediated by antibodies.
    J Neuroimmunol. 2007;192.
    PubMed     Related articles    Abstract available
    
    
    November 2007
41. D'AGUANNO S , Barassi A, Lupisella S, d'eril GM, et al
    Differential cerebro spinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. MIROWSKA-GUZEL D , Mach A, Gromadzka G, Czlonkowski A, et al
    BDNF A196G and C270T gene polymorphisms and susceptibility to multiple sclerosis in the polish population. Gender differences.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. SATTLER MB , Togni M, Gadjanski I, Suhs KW, et al
    Strain-specific susceptibility for neurodegeneration in a rat model of autoimmune optic neuritis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. CROXFORD JL , Pryce G, Jackson SJ, Ledent C, et al
    Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
45. SAKTHIVEL P , Ramanujam R, Wang XB, Pirskanen R, et al
    Programmed Death-1: From gene to protein in autoimmune human myasthenia gravis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. PACHNER AR
    Measurement of binding anti-IFNbeta antibodies in IFNbeta-treated MS patients: Lessons for the clinician and basic scientist.
    J Neuroimmunol. 2007;.
    PubMed     Related articles   
    
    
    
47. MOLDOVAN IR , Cotleur AC, Zamor N, Butler RS, et al
    Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
48. GUAN Y , Yu S, Zhao Z, Ciric B, et al
    Antigen presenting cells treated in vitro by macrophage colony-stimulating factor and autoantigen protect mice from autoimmunity.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. CHI LJ , Wang HB, Zhang Y, Wang WZ, et al
    Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barre syndrome.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. WINGES KM , Gilden DH, Bennett JL, Yu X, et al
    Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. FAINARDI E , Rizzo R, Melchiorri L, Stignani M, et al
    Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting Multiple Sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
52. WILLENBORG DO , Staykova M
    Reglation of neuroinflammation.
    J Neuroimmunol. 2007;191.
    PubMed     Related articles   
    
    
    
53. WEISS HA , Millward JM, Owens T
    CD8+ T cells in inflammatory demyelinating disease.
    J Neuroimmunol. 2007;191.
    PubMed     Related articles    Abstract available
    
    
    
54. SEGAL BM
    The role of natural killer cells in curbing neuroinflammation.
    J Neuroimmunol. 2007;191.
    PubMed     Related articles    Abstract available
    
    
    October 2007
55. FLUGEL A , Odoardi F, Nosov M, Kawakami N, et al
    Autoaggressive effector T cells in the course of experimental autoimmune encephalomyelitis visualized in the light of two-photon microscopy.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. URCELAY E , Blanco-Kelly F, de Las Heras V, de la Concha EG, et al
    TLR4 haplotypes in multiple sclerosis: A case-control study in the Spanish population.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
57. BLANCHIN S , Coffin C, Viader F, Ruf J, et al
    Anti-thyroperoxidase antibodies from patients with Hashimoto's encephalopathy bind to cerebellar astrocytes.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
58. DELUNARDO F , Margutti P, Pontecorvo S, Colasanti T, et al
    Screening of a microvascular endothelial cDNA library identifies rabaptin 5 as a novel autoantigen in Alzheimer's disease.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
59. MOSSBERG N , Andersen O, Nilsson S, Dahlgren C, et al
    Oxygen radical production and severity of the Guillain-Barre syndrome.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
60. CORREALE J , Farez M
    Monocyte-derived dendritic cells in multiple sclerosis: The effect of bacterial infection.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
61. MUZIO L , Martino G, Furlan R
    Multifaceted aspects of inflammation in multiple sclerosis: The role of microglia.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
62. ASTIER AL , Hafler DA
    Abnormal Tr1 differentiation in multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
63. PENDER MP
    Treating autoimmune demyelination by augmenting lymphocyte apoptosis in the central nervous system.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
64. LI J , Ridgway W, Fathman CG, Tse HY, et al
    High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
65. STUART R , Lovett-Racke AE, Frohman EM, Hawker K, et al
    Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. KORN T , Anderson AC, Bettelli E, Oukka M, et al
    The dynamics of effector T cells and Foxp3(+) regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. LUNDMARK F , Duvefelt K, Hillert J
    Genetic association analysis of the interleukin 7 gene (IL7) in multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. PACHNER AR , Brady J, Narayan K
    Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody.
    J Neuroimmunol. 2007;190.
    PubMed     Related articles    Abstract available
    
    
    
69. PRINCE HE , Lape-Nixon M, Audette C, Van Horn K, et al
    Identification of interferon-beta antibodies in a reference laboratory setting: findings for 1144 consecutive sera.
    J Neuroimmunol. 2007;190.
    PubMed     Related articles    Abstract available
    
    
    
70. SOKOL DK , O'Brien RS, Wagenknecht DR, Rao T, et al
    Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis.
    J Neuroimmunol. 2007;190.
    PubMed     Related articles    Abstract available
    
    
    
71. DYMENT DA , Ebers GC
    Microsatellites and genome scans-- a GAMES postscript.
    J Neuroimmunol. 2007;190.
    PubMed     Related articles   
    
    
    
72. DATI G , Quattrini A, Bernasconi L, Malaguti MC, et al
    Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies.
    J Neuroimmunol. 2007;190.
    PubMed     Related articles    Abstract available
    
    
    September 2007
73. YAMAMURA T , Sakuishi K, Illes Z, Miyake S, et al
    Understanding the behavior of invariant NKT cells in autoimmune diseases.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
74. FRISULLO G , Mirabella M, Angelucci F, Caggiula M, et al
    The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
75. WILLENBORG DO , Staykova M, Fordham S, O'brien N, et al
    The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. MATSUMOTO Y , Kohyama K, Park IK, Nakajima M, et al
    Characterization of pathogenic T cells and autoantibodies in C-protein-induced autoimmune polymyositis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. BYNOE MS , Bonorino P, Viret C
    Control of experimental autoimmune encephalomyelitis by CD4(+) suppressor T cells: Peripheral versus in situ immunoregulation.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
78. BUTTMANN M , Merzyn C, Hofstetter HH, Rieckmann P, et al
    TRAIL, CXCL10 and CCL2 plasma levels during long-term Interferon-beta treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
79. VAN VEEN T , Nielsen J, Berkhof J, Barkhof F, et al
    CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
80. RIVEROL M , Sepulcre J, Fernandez-Alonso M, Uccelli A, et al
    Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of Multiple Sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles   
    
    
    
81. GLADSTONE DE , Golightly MG, Brannagan TH 3rd
    High dose cyclophosphamide preferentially targets naive T (CD45/CD4/RA+) cells in CIDP and MS patients.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
82. GIBBS E , Oger J
    The IgG subclass-specificities of anti-IFNbeta antibodies change with time and differ between the IFNbeta products in relapsing remitting multiple sclerosis patients.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
83. KRUMBHOLZ M , Theil D, Steinmeyer F, Cepok S, et al
    CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. KUWABARA S , Misawa S, Takahashi H, Sawai S, et al
    Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle.
    J Neuroimmunol. 2007;189.
    PubMed     Related articles    Abstract available
    
    
    
85. HARIZI H , Homo-Delarche F, Amrani A, Coulaud J, et al
    Marked genetic differences in the regulation of blood glucose under immune and restraint stress in mice reveals a wide range of corticosensitivity.
    J Neuroimmunol. 2007;189.
    PubMed     Related articles    Abstract available
    
    
    
86. KUERTEN S , Kostova-Bales DA, Frenzel LP, Tigno JT, et al
    MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.
    J Neuroimmunol. 2007;189.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
87. NAYAK MS , Weinshenker B, Kerr DA
    2006 rare neuroimmunological disorders symposium; Sheraton Inner Harbor, Baltimore, MD, July 20-23, 2006.
    J Neuroimmunol. 2007;189.
    PubMed     Related articles   
    
    
    August 2007
88. IMAM SA , Guyton MK, Haque A, Vandenbark A, et al
    Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
89. GELEIJNS K , Emonts M, Laman JD, van Rijs W, et al
    Genetic polymorphisms of macrophage-mediators in Guillain-Barre syndrome.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
90. KOSTELIDOU K , Trakas N, Tzartos SJ
    Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: A combination of immunoadsorbents results in increased efficiency.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
91. HAYASHI A , Shiono H, Ohta M, Ohta K, et al
    Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
92. O'DOHERTY C , Roos IM, Antiguedad A, Aransay AM, et al
    ITGA4 polymorphisms and susceptibility to multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
93. BRUM DG , Barreira AA, Louzada-Junior P, Mendes-Junior CT, et al
    Association of the HLA-DRB1()15 allele group and the DRB1()1501 and DRB1()1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
94. TSUNODA I , Libbey JE, Fujinami RS
    Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity.
    J Neuroimmunol. 2007;188.
    PubMed     Related articles    Abstract available
    
    
    July 2007
95. KOSMACZEWSKA A , Bilinska M, Ciszak L, Noga L, et al
    Different patterns of activation markers expression and CD4+ T-cell responses to ex vivo stimulation in patients with clinically quiescent multiple sclerosis (MS).
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
96. ZIVKOVIC M , Djuric T, Dincic E, Raicevic R, et al
    Matrix metalloproteinase-9 -1562 C/T gene polymorphism in Serbian patients with multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
97. STEWART N , Taylor B, Ponsonby AL, Pittas F, et al
    The effect of season on cytokine expression in multiple sclerosis and healthy subjects.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
98. SARCHIELLI P , Di Filippo M, Candeliere A, Chiasserini D, et al
    Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
99. CAPRA R , Sottini A, Cordioli C, Serana F, et al
    IFNbeta bioavailability in multiple sclerosis patients: MxA versus antibody-detecting assays.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
100. SIDERIS S , Lagoumintzis G, Kordas G, Kostelidou K, et al
     Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: Receptor loss in cell culture.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
101. MARTINEZ A , Mas A, de Las Heras V, Bartolome M, et al
     FcRL3 and multiple sclerosis pathogenesis: Role in autoimmunity?
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
102. CANNELLA B , Gaupp S, Omari KM, Raine CS, et al
     Multiple sclerosis: Death receptor expression and oligodendrocyte apoptosis in established lesions.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
103. GAVALAS E , Kountouras J, Deretzi G, Boziki M, et al
     Helicobacter pylori and multiple sclerosis.
     J Neuroimmunol. 2007;.
     PubMed     Related articles   
     
     
     
104. KANTOR AB , Deng J, Waubant E, Lin H, et al
     Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
105. ANDREOLI V , Cittadella R, Valentino P, Condino F, et al
     The role of VLA4 polymorphisms in multiple sclerosis: An association study.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
106. JACOB A , Matiello M, Wingerchuk DM, Lucchinetti CF, et al
     Neuromyelitis optica: changing concepts.
     J Neuroimmunol. 2007;187.
     PubMed     Related articles    Abstract available
     
     
     
107. HOFSTETTER HH , Kovalovsky A, Shive CL, Lehmann PV, et al
     Neonatal induction of myelin-specific Th1/Th17 immunity does not result in experimental autoimmune encephalomyelitis and can protect against the disease in adulthood.
     J Neuroimmunol. 2007;187.
     PubMed     Related articles    Abstract available
     
     
     June 2007
108. KUIJF ML , Godschalk PC, Gilbert M, Endtz HP, et al
     Origin of ganglioside complex antibodies in Guillain-Barre syndrome.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
109. WEINSTOCK-GUTTMAN B , Zivadinov R, Tamano-Blanco M, Abdelrahman N, et al
     Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
110. SOUAYAH N , Mian NF, Gu Y, Ilyas AA, et al
     Elevated anti-sulfatide antibodies in Guillain-Barre syndrome in T cell depleted at end-stage AIDS.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
111. GERHAUSER I , Alldinger S, Baumgartner W
     Ets-1 represents a pivotal transcription factor for viral clearance, inflammation, and demyelination in a mouse model of multiple sclerosis.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
112. AIRAS L , Nikula T, Huang YH, Lahesmaa R, et al
     Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
113. DOKAI H , Nomura Y, Fujikawa Y, Nihei K, et al
     A study of the factors inducing the development of childhood-onset myasthenia gravis using CDR3 spectratyping analysis of the TCR repertoire.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
114. KLEITER I , Pedre X, Mueller AM, Poeschl P, et al
     Inhibition of Smad7, a negative regulator of TGF-beta signaling, suppresses autoimmune encephalomyelitis.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     May 2007
115. FABRIEK BO , Moller HJ, Vloet RP, van Winsen LM, et al
     Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
116. JASKOWSKI TD , Prince HE, Greer RW, Litwin CM, et al
     Further comparisons of assays for detecting MAG IgM autoantibodies.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
117. HEGGARTY S , Suppiah V, Silversides J, O'doherty C, et al
     CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
118. JACOBI C , Lange P, Reiber H
     Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: Discrimination between microorganism-driven and polyspecific immune response.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
119. CARRITHERS MD , Carrithers LM, Czyzyk J, Henegariu O, et al
     Characterization of a severe parenchymal phenotype of experimental autoimmune encephalomyelitis in (C57BL6xB10.PL)F1 mice.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
120. GARG N , Zivadinov R, Ramanathan M, Vasiliu I, et al
     Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
121. MATSUMOTO Y , Sakuma H, Kohyama K, Park IK, et al
     Paralysis of CD4(+)CD25(+) regulatory T cell response in chronic autoimmune encephalomyelitis.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
122. GOLD R , Jawad A, Miller DH, Henderson DC, et al
     Expert opinion: Guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapies.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
123. BRUDEK T , Luhdorf P, Christensen T, Hansen HJ, et al
     Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
124. KALMAN B , Laitinen K, Komoly S
     The involvement of mitochondria in the pathogenesis of multiple sclerosis.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
125. CASTELLI L , Comi C, Chiocchetti A, Nicola S, et al
     ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
126. LIN HH , Wang MX, Spies JM, Pollard JD, et al
     Effective treatment of experimental autoimmune neuritis with Fc fragment of human immunoglobulin.
     J Neuroimmunol. 2007;186.
     PubMed     Related articles    Abstract available
     
     
     
127. REINKE EK , Lee J, Zozulya A, Karman J, et al
     Short-term sPECAM-Fc treatment ameliorates EAE while chronic use hastens onset of symptoms.
     J Neuroimmunol. 2007;186.
     PubMed     Related articles    Abstract available
     
     
     
128. LAMBRACHT-WASHINGTON D , O'Connor KC, Cameron EM, Jowdry A, et al
     Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS.
     J Neuroimmunol. 2007;186.
     PubMed     Related articles    Abstract available
     
     
     
129. NI J , Shu YY, Zhu YN, Fu YF, et al
     COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-gamma and IL-10 production by inhibiting T-bet expression.
     J Neuroimmunol. 2007;186.
     PubMed     Related articles    Abstract available
     
     
     
130. BANG H , Mazumdar M, Zaykin D
     A letter to the editor in reply to "susceptibility to guillain-barre syndrome is associated to polymorphisms of CD1 genes" by Caporale et al. in the J of Neuroimmunology (2006), 177:112-118.
     J Neuroimmunol. 2007;186.
     PubMed     Related articles   
     
     
     
131. LU MO , Duan RS, Quezada HC, Chen ZG, et al
     Aggravation of experimental autoimmune neuritis in TNF-alpha receptor 1 deficient mice.
     J Neuroimmunol. 2007;186.
     PubMed     Related articles    Abstract available
     
     
     
132. DE ANGELIS MV , Notturno F, Caporale CM, Pace M, et al
     Polymorphisms of CD1 genes in chronic dysimmune neuropathies.
     J Neuroimmunol. 2007;186.
     PubMed     Related articles    Abstract available
     
     
     
133. VAN WINSEN LM , Hooper-van Veen T, van Rossum EF, Koper JW, et al
     Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS.
     J Neuroimmunol. 2007;186.
     PubMed     Related articles    Abstract available
     
     
     
134. ERCOLINI AM , Ludovic Croxford J, Degutes M, Miller SD, et al
     Cross-reactivity between peptide mimics of the immunodominant myelin proteolipid protein epitope PLP139-151: comparison of peptide priming in CFA vs. viral delivery.
     J Neuroimmunol. 2007;186.
     PubMed     Related articles    Abstract available
     
     
     April 2007
135. LEHMENSIEK V , Sussmuth SD, Brettschneider J, Tauscher G, et al
     Proteome analysis of cerebrospinal fluid in Guillain-Barre syndrome (GBS).
     J Neuroimmunol. 2007;185.
     PubMed     Related articles    Abstract available
     
     
     
136. YUN W , Hua-bing W, Wei-zhi W
     A study of associated cell-mediated immune mechanisms in experimental autoimmune neuritis rats.
     J Neuroimmunol. 2007;185.
     PubMed     Related articles    Abstract available
     
     
     
137. KAKOULIDOU M , Wang X, Zhao X, Pirskanen R, et al
     Soluble costimulatory factors sCD28, sCD80, sCD86 and sCD152 in relation to other markers of immune activation in patients with myasthenia gravis.
     J Neuroimmunol. 2007;185.
     PubMed     Related articles    Abstract available
     
     
     
138. WOLF NA , Amouzegar TK, Swanborg RH
     Synergistic interaction between Toll-like receptor agonists is required for induction of experimental autoimmune encephalomyelitis in Lewis rats.
     J Neuroimmunol. 2007;185.
     PubMed     Related articles    Abstract available
     
     
     
139. FARRUGIA ME , Bonifati DM, Clover L, Cossins J, et al
     Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.
     J Neuroimmunol. 2007;185.
     PubMed     Related articles    Abstract available
     
     
     
140. HOELDTKE RD , Hampe CS, Bekris LM, Hobbs G, et al
     Antibodies to GAD65 and peripheral nerve function in the DCCT.
     J Neuroimmunol. 2007;185.
     PubMed     Related articles    Abstract available
     
     
     
141. CHENG X , Zhao Z, Ventura E, Gran B, et al
     The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma.
     J Neuroimmunol. 2007;185.
     PubMed     Related articles    Abstract available
     
     
     March 2007
142. COMABELLA M , Martin R
     Genomics in multiple sclerosis-Current state and future directions.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
143. RAMAGOPALAN SV , Deluca GC, Morrison KM, Herrera BM, et al
     No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
144. PACHNER AR , Li L, Narayan K
     Intrathecal antibody production in an animal model of multiple sclerosis.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     February 2007
145. SOTGIU S , Sannella AR, Conti B, Arru G, et al
     Multiple sclerosis and anti-Plasmodium falciparum innate immune response.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
146. GRABER JJ , Ford D, Zhan M, Francis G, et al
     Cytokine changes during interferon-beta therapy in multiple sclerosis: Correlations with interferon dose and MRI response.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
147. KANTENGWA S , Weber MS, Juillard C, Benkhoucha M, et al
     Inhibition of naive Th1 CD4(+) T cells by glatiramer acetate in multiple sclerosis.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
148. LI W , Minohara M, Su JJ, Matsuoka T, et al
     Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
149. BROD SA , Hood Z
     Ingested (oral) SIRS peptide 1-21 inhibits acute EAE by inducing Th2-like cytokines.
     J Neuroimmunol. 2007;183.
     PubMed     Related articles    Abstract available
     
     
     January 2007
150. ADAMS JE , Webb MS, Hu X, Staunton D, et al
     Disruption of the beta(2)-integrin CD11d (alpha(D)beta2) gene fails to protect against experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
151. SURYANI S , Sutton I
     An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
152. PRITCHARD J , Makowska A, Gregson NA, Hayday AC, et al
     Reduced circulating CD4+CD25+ cell populations in Guillain-Barre syndrome.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
153. AKTAS O , Waiczies S, Zipp F
     Neurodegeneration in autoimmune demyelination: Recent mechanistic insights reveal novel therapeutic targets.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
154. DUAN RS , Zhang XM, Mix E, Quezada HC, et al
     IL-18 deficiency inhibits both Th1 and Th2 cytokine production but not the clinical symptoms in experimental autoimmune neuritis.
     J Neuroimmunol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
155. BROK HP , Boven L, van Meurs M, Kerlero de Rosbo N, et al
     The human CMV-UL86 peptide 981-1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys.
     J Neuroimmunol. 2007;182.
     PubMed     Related articles    Abstract available
     
     
     
156. ZIMECKI M , Kocieba M, Chodaczek G, Houszka M, et al
     Lactoferrin ameliorates symptoms of experimental encephalomyelitis in Lewis rats.
     J Neuroimmunol. 2007;182.
     PubMed     Related articles    Abstract available
     
     
     
157. KAIDA K , Morita D, Kanzaki M, Kamakura K, et al
     Anti-ganglioside complex antibodies associated with severe disability in GBS.
     J Neuroimmunol. 2007;182.
     PubMed     Related articles    Abstract available
     
     
     December 2006
158. TISCHNER D , Weishaupt A, van den Brandt J, Ip CW, et al
     Antigen therapy of experimental autoimmune encephalomyelitis selectively induces apoptosis of pathogenic T cells.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
159. PETERSON LK , Tsunoda I, Masaki T, Fujinami RS, et al
     Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
160. TAYLOR JM , Pollard JD
     Soluble TNFR1 inhibits the development of experimental autoimmune neuritis by modulating blood-nerve-barrier permeability and inflammation.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
161. PETERSON LK , Fujinami RS
     Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
162. HAN G , Shao H, Peng Y, Zhang P, et al
     Suppressor role of rat CD8(+)CD45RC(low) T cells in experimental autoimmune uveitis (EAU).
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
163. OLIVER B , Mayorga C, Fernandez V, Leyva L, et al
     Interferon receptor expression in multiple sclerosis patients.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
164. DIEM R , Sattler MB, Bahr M
     Neurodegeneration and -protection in autoimmune CNS inflammation.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
165. STEININGER C , Seiser A, Gueler N, Puchhammer-Stockl E, et al
     Primary cytomegalovirus infection in patients with Guillain-Barre syndrome.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
166. CARTER LL , Leach MW, Azoitei ML, Cui J, et al
     PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
167. CUNNINGHAM S , O'doherty C, Patterson C, McDonnell G, et al
     The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
168. HARP C , Lee J, Lambracht-Washington D, Cameron E, et al
     Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
169. CID C , Regidor I, Alcazar A
     Anti-heat shock protein 90beta antibodies are detected in patients with multiple sclerosis during remission.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
170. DE ANDRES C , Aristimuno C, de Las Heras V, Martinez-Gines ML, et al
     Interferon beta-1a therapy enhances CD4(+) regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
171. VAN SORGE NM , Yuki N, Koga M, Susuki K, et al
     Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain-Barre syndrome.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
172. SASAJIMA T , Watanabe H, Sato S, Sato Y, et al
     Anti-triosephosphate isomerase antibodies in cerebrospinal fluid are associated with neuropsychiatric lupus.
     J Neuroimmunol. 2006;181.
     PubMed     Related articles    Abstract available
     
     
     
173. MATA S , Borsini W, Caldini A, De Scisciolo G, et al
     Long-term evolution of anti-ganglioside antibody levels in patient with chronic dysimmune neuropathy under IVIg therapy.
     J Neuroimmunol. 2006;181.
     PubMed     Related articles    Abstract available
     
     
     November 2006
174. TUZUN E , Li J, Saini SS, Yang H, et al
     Pros and cons of treating murine myasthenia gravis with anti-C1q antibody.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
175. WEINSTOCK-GUTTMAN B , Tamano-Blanco M, Bhasi K, Zivadinov R, et al
     Pharmacogenetics of MXA SNPs in interferon-beta treated multiple sclerosis patients.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
176. CHRISTENSEN T , Petersen T, Thiel S, Brudek T, et al
     Gene-environment interactions in multiple sclerosis: Innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
177. EL BEHI M , Zephir H, Lefranc D, Dutoit V, et al
     Changes in self-reactive IgG antibody repertoire after treatment of experimental autoimmune encephalomyelitis with anti-allergic drugs.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
178. HAEGELE KF , Stueckle CA, Malin JP, Sindern E, et al
     Increase of CD8+ T-effector memory cells in peripheral blood of patients with relapsing-remitting multiple sclerosis compared to healthy controls.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
179. DRESSEL A , Vogelgesang A, Brinkmeier H, Mader M, et al
     Glatiramer acetate-specific human CD8+ T cells: Increased IL-4 production in multiple sclerosis is reduced by glatiramer acetate treatment.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
180. REINKE EK , Johnson MJ, Ling C, Karman J, et al
     Substance P receptor mediated maintenance of chronic inflammation in EAE.
     J Neuroimmunol. 2006;180.
     PubMed     Related articles    Abstract available
     
     
     
181. REINDL M , Khalil M, Berger T
     Antibodies as biological markers for pathophysiological processes in MS.
     J Neuroimmunol. 2006;180.
     PubMed     Related articles    Abstract available
     
     
     
182. GIOVANNONI G , Chapman MD, Thompson EJ
     The role of antibody affinity for specific antigens in the differential diagnosis of inflammatory nervous system disorders.
     J Neuroimmunol. 2006;180.
     PubMed     Related articles    Abstract available
     
     
     October 2006
183. KRAKAUER M , Sorensen PS, Sellebjerg F
     CD4+ memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
184. JOVANOVA-NESIC K , Shoenfeld Y
     MMP-2, VCAM-1 and NCAM-1 expression in the brain of rats with experimental autoimmune encephalomyelitis as a trigger mechanism for synaptic plasticity and pathology.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
185. TUZUN E , Saini SS, Morgan BP, Christadoss P, et al
     Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
186. BUENAFE AC , Bourdette DN
     Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
187. LUTTEROTTI A , Kuenz B, Gredler V, Khalil M, et al
     Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
188. ARCHAMBAULT AS , Sim J, McCandless EE, Klein RS, et al
     Region-specific regulation of inflammation and pathogenesis in experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
189. GRONEN F , Ruprecht K, Weissbrich B, Klinker E, et al
     Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
190. LUNDMARK F , Harbo HF, Celius EG, Saarela J, et al
     Association analysis of the LAG3 and CD4 genes in multiple sclerosis in two independent populations.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
191. JENSEN J , Langkilde AR, Frederiksen JL, Sellebjerg F, et al
     CD8+ T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-beta treatment.
     J Neuroimmunol. 2006;179.
     PubMed     Related articles    Abstract available
     
     
     
192. MA X , Foster J, Sakic B
     Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice.
     J Neuroimmunol. 2006;179.
     PubMed     Related articles    Abstract available
     
     
     
193. KIRVAN CA , Swedo SE, Snider LA, Cunningham MW, et al
     Antibody-mediated neuronal cell signaling in behavior and movement disorders.
     J Neuroimmunol. 2006;179.
     PubMed     Related articles    Abstract available
     
     
     September 2006
194. KUMAR M , Putzki N, Limmroth V, Remus R, et al
     CD4(+)CD25(+)FoxP3(+) T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
195. HASSEN GW , Feliberti J, Kesner L, Stracher A, et al
     A novel calpain inhibitor for the treatment of acute experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
196. SUN X , Minohara M, Kikuchi H, Ishizu T, et al
     The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
197. MIKOL DD , Ditlow C, Usatin D, Biswas P, et al
     Serum IgE reactive against small myelin protein-derived peptides is increased in multiple sclerosis patients.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
198. O'NEILL EJ , Day MJ, Wraith DC
     IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE.
     J Neuroimmunol. 2006;178.
     PubMed     Related articles    Abstract available
     
     
     
199. RAIKWAR HP , Muthian G, Rajasingh J, Johnson CN, et al
     PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
     J Neuroimmunol. 2006;178.
     PubMed     Related articles    Abstract available
     
     
     
200. RATTS RB , Lovett-Racke AE, Choy J, Northrop SC, et al
     CD28-CD57+ T cells predominate in CD8 responses to glatiramer acetate.
     J Neuroimmunol. 2006;178.
     PubMed     Related articles    Abstract available
     
     
     
201. MI W , Prentice TW, Young CR, Johnson RR, et al
     Restraint stress decreases virus-induced pro-inflammatory cytokine mRNA expression during acute Theiler's virus infection.
     J Neuroimmunol. 2006;178.
     PubMed     Related articles    Abstract available
     
     
     
202. SCARISBRICK IA , Blaber SI, Tingling JT, Rodriguez M, et al
     Potential scope of action of tissue kallikreins in CNS immune-mediated disease.
     J Neuroimmunol. 2006;178.
     PubMed     Related articles    Abstract available
     
     
     August 2006
203. TATSUMOTO M , Koga M, Gilbert M, Odaka M, et al
     Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
     J Neuroimmunol. 2006;177.
     PubMed     Related articles    Abstract available
     
     
     
204. LEES JR , Archambault AS, Russell JH
     T-cell trafficking competence is required for CNS invasion.
     J Neuroimmunol. 2006;177.
     PubMed     Related articles    Abstract available
     
     
     
205. KUERTEN S , Lichtenegger FS, Faas S, Angelov DN, et al
     MBP-PLP fusion protein-induced EAE in C57BL/6 mice.
     J Neuroimmunol. 2006;177.
     PubMed     Related articles    Abstract available
     
     
     
206. ALAEDINI A , Latov N
     Transglutaminase-independent binding of gliadin to intestinal brush border membrane and GM1 ganglioside.
     J Neuroimmunol. 2006;177.
     PubMed     Related articles    Abstract available
     
     
     
207. JANKE AD , Giuliani F, Yong VW
     IVIg attenuates T cell-mediated killing of human neurons.
     J Neuroimmunol. 2006;177.
     PubMed     Related articles    Abstract available
     
     
     
208. SIEVE AN , Steelman AJ, Young CR, Storts R, et al
     Sex-dependent effects of chronic restraint stress during early Theiler's virus infection on the subsequent demyelinating disease in CBA mice.
     J Neuroimmunol. 2006;177.
     PubMed     Related articles    Abstract available
     
     
     
209. ARUNA BV , Sela M, Mozes E
     Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+ CD25+ regulatory cells.
     J Neuroimmunol. 2006;177.
     PubMed     Related articles    Abstract available
     
     
     
210. HEINE S , Ebnet J, Maysami S, Stangel M, et al
     Effects of interferon-beta on oligodendroglial cells.
     J Neuroimmunol. 2006;177.
     PubMed     Related articles    Abstract available
     
     
     July 2006
211. WANG C , Chou YK, Rich CM, Link JM, et al
     AlphaB-crystallin-reactive T cells from knockout mice are not encephalitogenic.
     J Neuroimmunol. 2006;176.
     PubMed     Related articles    Abstract available
     
     
     
212. XU J , Chavis JA, Racke MK, Drew PD, et al
     Peroxisome proliferator-activated receptor-alpha and retinoid X receptor agonists inhibit inflammatory responses of astrocytes.
     J Neuroimmunol. 2006;176.
     PubMed     Related articles    Abstract available
     
     
     
213. VYSHKINA T , Kalman B
     Analyses of a MS-associated haplotype encompassing the CCL3 gene.
     J Neuroimmunol. 2006;176.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: